Human peripheral blood lymphocytes stained with purified DJR2-4, followed by biotinylated anti-mouse IgG and Sav-PE
TNFRSF10B / Killer / DR5 Antibody (Extracellular Domain, clone DJR2-4 (7-8))
Primary AntibodyLSBio Guarantee
| Antibody: | Mouse Monoclonal |
| Applications: | Flow Cytometry, Immunohistochemistry (general) |
| Reactivity: | Human |
| Format: | Liquid |
$351.00each
Catalog Number: LS-C40991-100
Catalog Number: LS-C40991
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- DR5 antibody LS-C40991 is an unconjugated mouse monoclonal antibody to human DR5 (TNFRSF10B / Killer) (Extracellular Domain). Validated for Flow. Cited in 1 publication.
- Application
- FC, IHC
- Reactivity
- Hu
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Monoclonal Antibodies
- Alternative Names
- Cytotoxic TRAIL receptor-2 | CD262 antigen | DR5 | Death receptor 5 | KILLER | TRAIL-R2 | TRICK2B | TNFRSF10B | TRAILR2 | TRICK2A | TRICKB | TRICK2 | CD262 | Fas-like protein | TRAIL receptor 2 | ZTNFR9
- UniProt Number
- O14763|Q6FH58
- NCBI GenBank
- NM_147187
- SwissProt
- O14763
Target
- Target
- Human TNFRSF10B / Killer / DR5
- Antigen Species
- Human
- Epitope
- Extracellular domain of DR5-human IgG1 Fc fusion protein
- Gene Name
- TNFRSF10B
Antibody
- Host Species
- Mouse
- Clonality
- Monoclonal
- Clone
- DJR2-4 (7-8)
- Isotype
- IgG1
Immunogen
- Immunogen
- Recombinant human TNFRSF10B / DR5.
- Immunogen Type
- Recombinant Immunogen
Format
- Conjugate/Label
- Unconjugated
- Format
- Liquid
- Formulation
- Phosphate-buffered solution, pH 7.2, 0.09% sodium azide.
- Concentration
- 0.5 mg/mL
- Preservative
- Yes
- Purification Method
- Affinity Purified
Storage & Handling
- Storage Conditions
- Store at 4°C. Avoid freezing.
- Recommended Storage Buffer
- Phosphate-buffered
Bortezomib and depsipeptide sensitize tumors to tumor necrosis factor-related apoptosis-inducing ligand: a novel method to potentiate natural killer cell tumor cytotoxicity. Lundqvist A, Abrams SI, Schrump DS, Alvarez G, Suffredini D, Berg M, Childs R. Cancer research. 2006;66:7317-25. PubMed: 16849582